Skip to main content

Table 1 Case profiles

From: Phenotypic variability of Niemann-Pick disease type C including a case with clinically pure schizophrenia: a case report

 

Case 1

Case 2

Case 3

Age at onset (years)

11

27

22

Initial symptom

Intellectual disability

Painful dystonia

Schizophrenia

Age at diagnosis (years)

25

28

35

Visceral signs

 Splenomegaly

Mild

Mild

Mild

 Neonatal jaundice

+

None

None

Neurological signs

 VSGP

+

None

None

 Dysphagia

+

None

None

 Spastic ataxia

+

None

None

 IVM

Chorea, athetosis, dystonia, myoclonus

Dystonia

None

Psychiatric signs

 Cognitive decline

+

None

None

 Psychotic symptoms

+

+

+

NPC-SI a

 Percentile

98%

18%

32%

 RPS

183

47

67

Filipin pattern

Variant

Variant

Variant

ASM activity

221

213

165

(nmol/mg protein/h)

99% of control

95% of control

73% of control

Phenotype (cDx)

Juvenile

Adult

Adult

NPC1 gene mutations

 Father

c.1421C > T

c.3011C > T

c.3011C > T

(p.P474L)

(p.S1004 L)

(p.S1004 L)

 Mother

c.3722 T > C

c.160_161insG

c.160_161insG

(p.L1241S)

(p.D54GfsX4)

(p.D54GfsX4)

Brain MRI

Sl. atrophic

Normal

Sl. atrophic

Hypoperfusion on ECD-SPECT

Frontal

Frontal

Frontal

CSF Analysis

 p-Tau (<  55)

59 pg/mL

47 pg/mL

36 pg/mL

 h-Tau (<  300)

371 pg/mL

214 pg/mL

188 pg/mL

Cupper

 Serum Cu (>  68)

76 μg/dL

82 μg/dL

88 μg/dL

 Serum Cp (>  21)

22 mg/dL

18 mg/dL

22 mg/dL

 Urine Cu (>  20)

NA

NA

32 μg/day

Urine bile acid b

 SNAG-Δ5-CT (<  11)

NA

13 ng/mL

92 ng/mL

 SNAG-Δ5-CA (<  282)

NA

42 ng/mL

317 ng/mL

 SNAG-Δ5-CG (<  258)

NA

69 ng/mL

481 ng/mL

  1. Abbreviations: ASM Acid sphingomyelinase; cDx Clinical diagnosis; Cp Ceruloplasmin; CSF Cerebrospinal fluid; Cu Copper; ECD-SPECT Technetium-99 m ethyl cysteinate dimer-single photon emission computed tomography; h-Tau Human tau protein; IVM Involuntary movements; MRI Magnetic resonance imaging; NA Not assessed; NPC-SI Niemann-Pick disease type C-suspicion index; p-Tau Phosphorylated tau protein; RPS Risk prediction score; VSGP Vertical supranuclear gaze palsy
  2. a) Hendriksz CJ, et al. J Rare Disord. 2015 [4]. b) Maekawa M, et al. Steroids. 2013 [7]